Bicara Therapeutics Inc. Common Stock (BCAX) — Long-term Investment Intensity
Bicara Therapeutics Inc. Common Stock (BCAX) has a Long-term Investment Intensity of 27.6% as of September 2025. Long-term investments of $117.42 Million represent 27.6% of total assets of $424.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Bicara Therapeutics Inc. Common Stock (BCAX) shareholders funds for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for Bicara Therapeutics Inc. Common Stock (None–None)
The table below presents the year-by-year Long-term Investment Intensity for Bicara Therapeutics Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BCAX company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|